c.novak
Submits third-party assay reports on material purchased directly. Based in Oulu.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.02%
n=6
Suppliers covered
5
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041652 | Liraglutide | QSC | QSC-2605-W8602 | Nordanalyt | 2026-Q3 | 99.33 | 6.55 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041835 | Semax | JEEP | JEEP-2602-C3015 | Medutest | 2026-Q1 | 99.08 | 8.04 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043197 | Semaglutide | GL Biochem | GLBI-2508-D8720 | VendorInvestigate | 2025-Q4 | 98.38 | 3.53 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019880 | AOD-9604 | SWB | SWB-2504-F5003 | Janoshik | 2025-Q3 | 98.96 | 2.63 | 96.2 | Buyer-sourced | 0 | PASS |
| AX-2024-005414 | BPC-157 | WXT | WXT-2410-J4489 | Janoshik | 2024-Q4 | 98.02 | 4.94 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004422 | Tirzepatide | QSC | QSC-2402-H8701 | Nordanalyt | 2024-Q1 | 99.45 | 1.71 | — | Supplier-supplied | 1 | MARGINAL |
| Supplier | Records | Median purity |
|---|---|---|
| QSC | 2 | n<3 |
| JEEP | 1 | n<3 |
| GL Biochem | 1 | n<3 |
| SWB | 1 | n<3 |
| WXT | 1 | n<3 |